Skip to main content
Go to Parent Project Muscular Dystrophy's website
Fundraiser Login
Open Mobile Menu
RACE
Join the Race
Endurance Races
.1K Series
DIY Race Series
Race Calendar
Athlete Resources
Fundraising Tips
Matching Gifts
Training Tips
Personal Fundraising Page FAQs
Get Inspired
SUPPORT
Support an Athlete
Become a Spirit Athlete
Corporate Sponsorship
Shop For Gear
ABOUT
Mission & Impact
FAQ
Contact Us
Donate
RACE
Join the Race
Endurance Races
.1K Series
DIY Race Series
Race Calendar
Athlete Resources
Fundraising Tips
Matching Gifts
Training Tips
Personal Fundraising Page FAQs
Get Inspired
SUPPORT
Support an Athlete
Become a Spirit Athlete
Corporate Sponsorship
Shop For Gear
ABOUT
Mission & Impact
FAQ
Contact Us
Donate
Close Menu
Cranbury Pharmaceuticals (Tris Pharma) Receives FDA Approval for First Generic Version of Emflaza® (deflazacort) for Duchenne
Written by
